Andrew Joseph Muir

Conference American Journal of Gastroenterology · October 1, 2025 Introduction: Anti-CD20 agents confer about a 10% risk of hepatitis B virus (HBV) reactivation in individuals with positive surface antigen (sAg) or core antibody (cAb). AGA guidelines from 2025 recommend sAg and cAb testing prior to therapy initiation. De ... Full text Cite

Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis.

Conference Hepatology · May 2022 BACKGROUND AND AIMS: Surrogate endpoints that predict complications are necessary for assessment and approval of NASH therapies. We assessed associations between histologic and noninvasive tests (NITs) of fibrosis with liver-related complications in patien ... Full text Link to item Cite

BLACK, OLDER, UNMARRIED, AND MEDICAID PATIENTS WERE LESS LIKELY TO COMPLETE HEPATOLOGY VIDEO VISITS DURING COVID-19

Conference HEPATOLOGY · November 2020 Link to item Cite

LONGITUDINAL CHANGES OF PRO-C3 AND ELF ARE ASSOCIATED WITH HISTOLOGIC AND CLINICAL DISEASE PROGRESSION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC)

Conference HEPATOLOGY · November 2020 Link to item Cite

SERUM AFP AS A DIAGNOSTIC MARKER OF HEPATOCELLULAR CARCINOMA IN LIRADS M LESIONS

Conference HEPATOLOGY · November 2020 Link to item Cite

Variations and Racial Disparities in Helicobacter pylori Guideline Adherence for Eradication Testing

Conference AMERICAN JOURNAL OF GASTROENTEROLOGY · October 2020 Link to item Cite

Antibiotic Resistance Rates in Helicobacter pylori Infection Derived from Retrospective Cure Rates

Conference AMERICAN JOURNAL OF GASTROENTEROLOGY · October 2020 Link to item Cite

Use of Skeletal Muscle Index as a Predictor of Wait-List Mortality in Patients With End-Stage Liver Disease.

Conference Liver Transpl · September 2020 The aim of this study is to validate a proposed definition of sarcopenia in predicting wait-list mortality. We retrospectively evaluated 355 adults (age ≥18 years) with cirrhosis listed for first-time LT from January 1, 2010, to April 1, 2018 from our cent ... Full text Link to item Cite

VALIDATION OF MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY RISK PREDICTION SCORES TO PREDICT CLINICAL EVENTS IN PRIMARY SCLEROSING CHOLANGITIS

Conference GASTROENTEROLOGY · May 2020 Link to item Cite

ASSOCIATIONS BETWEEN SEROLOGIC MARKERS OF EXTRACELLULAR MATRIX (ECM) REMODELING WITH FIBROSIS STAGE AND PROGNOSIS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC)

Conference HEPATOLOGY · October 1, 2019 Link to item Cite

RNA-SEQ FROM PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS IDENTIFIES A FIBROSIS-INDEPENDENT GENE EXPRESSION SIGNATURE THAT PREDICTS CLINICAL EVENTS

Conference HEPATOLOGY · October 1, 2019 Link to item Cite

EFFICACY AND ADHERENCE TO ORAL HEPATITIS C (HCV) TREATMENT THROUGH A DIGITAL MEDICINE PROGRAM (DMP) AMONG A POPULATION AT HIGH RISK FOR NONADHERENCE

Conference HEPATOLOGY · October 1, 2019 Link to item Cite

A LARGE PROPORTION OF NAFLD PATIENTS WITH ADVANCED FIBROSIS REMAIN CLINICALLY UNIDENTIFIED: AN ANALYSIS OF PCORNET DATA

Conference HEPATOLOGY · October 1, 2019 Link to item Cite

COURSE OF CIRRHOSIS REGRESSION: LESSONS FROM PATIENTS WITH HCV CIRRHOSIS FOLLOWING SUCCESSFUL SOFOSBUVIR-BASED TREATMENT

Conference HEPATOLOGY · October 1, 2019 Link to item Cite

1089 Hypophosphatemia in Patients With Alcoholic Hepatitis

Conference American Journal of Gastroenterology · October 2019 INTRODUCTION:Patients with alcoholic hepatitis suffer from high rates of malnutrition and are at risk for hypophosphatemia due to poor dietary intake, renal wasting, and r ... Full text Cite

The Alcohol Use Disorders Identification Test Screening in Patients with Hepatitis C

Conference HEPATOLOGY · October 1, 2018 Link to item Cite

The Impact of Advanced Age on Waiting List and Post-Transplantation Outcomes for NAFLD Patients

Conference HEPATOLOGY · October 1, 2018 Link to item Cite

TIPS Outcomes According to Race and Ethnicity

Conference AMERICAN JOURNAL OF GASTROENTEROLOGY · October 1, 2018 Link to item Cite

Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO.

Conference Hepatology · July 2018 UNLABELLED: Primary sclerosing cholangitis (PSC) is a chronic liver disease associated with inflammation and biliary fibrosis that leads to cholangitis, cirrhosis, and impaired quality of life. Our objective was to develop and validate a PSC-specific patie ... Full text Link to item Cite

ASSOCIATIONS OF ALCOHOL CONSUMPTION MOTIVES WITH DEPRESSION AND PAIN AMONG INDIVIDUALS WITH HEPATITIS C

Conference GASTROENTEROLOGY · May 1, 2018 Link to item Cite

HEPATITIS C INFECTION KNOWLEDGE AND AWARENESS AMONG WOMEN OF CHILDBEARING AGE

Conference GASTROENTEROLOGY · May 2018 Link to item Cite

Prospective validation of the Enhanced Liver Fibrosis (ELF) test for the prediction of disease progression in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis

Conference HEPATOLOGY · October 1, 2017 Link to item Cite

Radiologic progression in primary sclerosing cholangitis (PSC) by two-dimensional magnetic resonance cholangiopancreatography (MRCP): Prospective data from a randomized controlled trial

Conference HEPATOLOGY · October 1, 2017 Link to item Cite

A risk prediction score based on magnetic resonance cholangiopancreatography (MRCP) accurately predicts disease progression in patients with primary sclerosing cholangitis (PSC)

Conference HEPATOLOGY · October 1, 2017 Link to item Cite

Quantification of biliary tree volume in patients with PSC using three dimensional (3D) reconstruction of magnetic resonance cholangiopancreatography (MRCP): Clinical associations and prognostic significance

Conference HEPATOLOGY · October 1, 2017 Link to item Cite

Changes in Fibrosis, but not the Nafld Activity Score (NAS), are Associated with Disease Progression in Patients with Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis

Conference Gastroenterology · April 2017 Full text Cite

Improving HCV Testing in Alignment with Current Guidelines: Technology Alone is Not the Answer

Conference HEPATOLOGY · October 1, 2016 Link to item Cite

Phenotypic Differences in Primary Sclerosing Cholangitis by Age Group

Conference HEPATOLOGY · October 1, 2016 Link to item Cite

Hepatic expression of lysyl oxidase-like-2 ( LOXL2) in primary sclerosing cholangitis (PSC)

Conference HEPATOLOGY · October 1, 2016 Link to item Cite

The Impact of HLA Serotyping and HLA Matching for PSC, PSC/AIH, AIH, PBC/AIH, and PBC Patients on Post-Liver Transplant Graft Failure: an Analysis of the UNOS Database

Conference HEPATOLOGY · October 1, 2016 Link to item Cite

Bridging the gap: Facilitating linkage to care for persons identified with chronic hepatitis C infections through a public health program

Conference HEPATOLOGY · October 1, 2016 Link to item Cite

Long-Term Follow-up of Patients with Chronic HCV Infection and Compensated or Decompensated Cirrhosis Following Treatment with Sofosbuvir-Based Regimens

Conference HEPATOLOGY · October 1, 2016 Link to item Cite

Detecting DILI in Patients with Decompensated Chronic Hepatitis C: A Review of the SOLAR-1 and-2 Studies

Conference TRANSPLANTATION · May 1, 2016 Link to item Cite

Sofosbuvir/Velpatasvir Fixed Dose Combination For The Treatment Of HCV In Patients With Decompensated liver Disease: The Phase 3 ASTRAL-4 Study

Conference HEPATOLOGY · December 1, 2015 Link to item Cite